CAS: 1225497-78-8
![Glycine, N-[2-methoxy-5-[[[2-(2,4,6-trimethoxyphenyl)ethenyl]sulfonyl]methyl]phenyl]-, sodium sa...](https://static.cymitquimica.com/products/IN/thumb/DA0017G2.jpg)
Glycine, N-[2-methoxy-5-[[[2-(2,4,6-trimethoxyphenyl)ethenyl]sulfonyl]methyl]phenyl]-, sodium salt (1:1)
CAS:1225497-78-8
Fórmula:
C21H24NNaO8S
Pureza:
99%
Forma y color:
Solid
Peso molecular:
473.4719
Ref: IN-DA0017G2
| 10mg | 64,00 € | ||
| 25mg | 96,00 € | ||
| 50mg | 125,00 € | ||
| 100mg | 197,00 € |
Entrega estimada en Estados Unidos, el Martes 10 de Diciembre de 2024
(E/Z)-Rigosertib sodium
CAS:1225497-78-8
ON-01910 is a non-ATP-competitive PLK1 inhibitor(IC50 of 9 nM, in a cell-free assay).
Fórmula:
C21H24NNaO8S
Pureza:
97.16% - 99.82%
Forma y color:
Solid
Peso molecular:
473.47
Ref: TM-T6070
| 2mg | 40,00 € | ||
| 5mg | 60,00 € | ||
| 10mg | 94,00 € | ||
| 25mg | 181,00 € | ||
| 50mg | 339,00 € | ||
| 100mg | 580,00 € | ||
| 1mL*10mM (DMSO) | 79,00 € |
Entrega estimada en Estados Unidos, el Martes 17 de Diciembre de 2024
ON-01910 Sodium Salt
Producto controladoCAS:1225497-78-8
Applications Rigosertib (ON-01910) is a non-ATP-competitive inhibitor of Polo-like kinase 1 (PLK1). References Gumireddy, K., …
Fórmula:
C21H24NNaO8S
Forma y color:
Neat
Peso molecular:
473.47
Ref: TR-O657000
| 5mg | 109,00 € | ||
| 25mg | 422,00 € | ||
| 100mg | 1.204,00 € |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025
Rigosertib
CAS:1225497-78-8
Rigosertib is a small molecule that inhibits the activity of the protein ErbB2. It has …
Pureza:
Min. 95%
Ref: 3D-FR137713
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025
